An interventional study of laser speckle flowgraphy in Hypertension, Heart Failure and Vascular Ischemia, sponsored by Randy Kardon. Terminated at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-10.
Sponsored by Randy Kardon · Not applicable, Interventional, and Treatment
The purpose of this project is to quantify normal and abnormal skin blood flow regionally in different areas of the body(face, extremities, over burns and wounds) at baseline and over time in response to treatment or environmental changes, such as temperature, light and pressure.
Laser speckle skin blood flow (LSFG-SKIN) will be recorded in normal subjects and in patients with disorders affecting skin capillary perfusion, which may include cardiovascular disorders, dermatologic disorders, skin wounds, ocular disorders, psychiatric disorders, and neurologic disorders.
6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.
This study's enrollment of 1 is below the median of 100 across 4,575 interventional studies indexed under Hypertension.
Browse Hypertension studies →Randy Kardon is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Controls
●Healthy normal control subjects ages 18-90
Cardiology Subjects
Dermatology Subjects
Endocrine Subjects
Neurology Subjects
Psychiatry Subjects
Surgery Subjects
Ophthalmology Subjects
Exclusion Criteria:
Controls
Cardiology Subjects
Angle closure glaucoma
Endocrine Subjects
Neurology Subjects
Psychiatry Subjects
Surgery Subjects
Ophthalmology Subjects
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
TIA (transient ischaemic attack)
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
cardiology subjects, dermatology subjects, endocrine subjects, neurology subjects, psychiatry subjects, surgery subjects, ophthalmology subjects.
Device: laser speckle flowgraphy
blood flow state of the skin as real time two dimensional image
Imaging Blood Flow
Imaging blood flow in the tissue is of major importance in the clinical environment
Time frame: One visit
| Milestone | Clinic Subjects |
|---|---|
| Started | 1 |
| Completed | 1 |
| Not completed | 0 |
Imaging blood flow in the tissue is of major importance in the clinical environment
No measurements were reported for this outcome.
Collected over 1 year, 5 months.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Clinic Subjects | 0/1 (0%) | 0/1 (0%) | 0/1 (0%) |
female
| Age, Continuous(years) | Clinic Subjects |
|---|---|
| Mean | 55 |
| Sex: Female, Male(Participants) | Clinic Subjects |
|---|---|
| Female | 1 |
| Male | 0 |
| Race (NIH/OMB)(Participants) | Clinic Subjects |
|---|---|
| American Indian or Alaska Native | 0 |
| Asian | 0 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 0 |
| White | 1 |
| More than one race | 0 |
| Unknown or Not Reported | 0 |
Plan to share: No
Ran from May 2017 to primary completion in Mar 2019, 21 months.
Results were first posted in May 2023, 4 years 2 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Randy Kardon